Discover the intriguing link between elevated albuminuria levels and an increased risk of cancer development, shedding new light on potential early warning signs in nephrology.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
An increase in albuminuria is associated with a higher incidence of malignancies.
Luo et al., Clin Kidney J 2024
<!– DOI: 10.1093/ckj/sfae009 //–>
https://doi.org/10.1093/ckj/sfae009
This study investigates the relationship between changes in albuminuria, measured by the urine albumin-creatinine ratio (ACR), and the risk of developing cancer. Utilizing data from 64,303 participants in the Stockholm CREAtinine Measurements (SCREAM) project, who had no history of cancer and underwent at least two ACR tests within a two-year span, the research found that individuals with increasing ACR faced a 19% higher risk of overall cancer compared to those without clinically elevated ACR. This association was independent of baseline kidney function and initial ACR levels. Specifically, increased risks were noted for urinary tract and lung cancers, while no significant links were found for other site-specific cancers. This study highlights the potential of albuminuria changes as an independent predictor of cancer risk, emphasizing the importance of monitoring albuminuria not just for kidney health but also for its implications on cancer susceptibility.